Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease.

Brost S, Koschny R, Sykora J, Stremmel W, Lasitschka F, Walczak H, Ganten TM.

Pathol Res Pract. 2010 Jan 15;206(1):43-50. doi: 10.1016/j.prp.2009.09.005.

PMID:
19954896
2.

CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features.

Camacho FI, Muñoz C, Sánchez-Verde L, Sáez AI, Alcántara M, Rodríguez R.

Histopathology. 1999 Aug;35(2):144-9.

PMID:
10460659
3.

Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.

Griga T, May B, Pfisterer O, Müller KM, Brasch F.

Hepatogastroenterology. 2002 Jan-Feb;49(43):116-23.

PMID:
11941933
4.

Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.

Souza HS, Tortori CJ, Castelo-Branco MT, Carvalho AT, Margallo VS, Delgado CF, Dines I, Elia CC.

Int J Colorectal Dis. 2005 May;20(3):277-86.

PMID:
15503066
5.

Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.

Schauber J, Rieger D, Weiler F, Wehkamp J, Eck M, Fellermann K, Scheppach W, Gallo RL, Stange EF.

Eur J Gastroenterol Hepatol. 2006 Jun;18(6):615-21.

PMID:
16702850
6.

Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF.

Eur J Gastroenterol Hepatol. 2002 Jul;14(7):745-52.

PMID:
12169983
7.

TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections.

Sträter J, Walczak H, Pukrop T, Von Müller L, Hasel C, Kornmann M, Mertens T, Möller P.

Gastroenterology. 2002 Mar;122(3):659-66.

PMID:
11874999
8.

Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.

Daig R, Andus T, Aschenbrenner E, Falk W, Schölmerich J, Gross V.

Gut. 1996 Feb;38(2):216-22.

9.

Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.

Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM.

Gastroenterology. 2006 Jun;130(7):1962-74.

PMID:
16762619
10.

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A.

Clin Exp Immunol. 1993 Oct;94(1):174-81.

11.

Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF.

Dig Dis Sci. 1995 Mar;40(3):485-94.

PMID:
7895532
12.
13.
14.

Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.

Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA.

Dig Liver Dis. 2008 Aug;40(8):673-9. doi: 10.1016/j.dld.2008.02.010.

PMID:
18374637
15.

Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis.

Raddatz D, Middel P, Bockemühl M, Benöhr P, Wissmann C, Schwörer H, Ramadori G.

Aliment Pharmacol Ther. 2004 Jan 1;19(1):47-61.

PMID:
14687166
16.

Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

Goode T, O'Connell J, Anton P, Wong H, Reeve J, O'Sullivan GC, Collins JK, Shanahan F.

Gut. 2000 Sep;47(3):387-96.

17.

Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease.

Rogler G, Meinel A, Lingauer A, Michl J, Zietz B, Gross V, Lang B, Andus T, Schölmerich J, Palitzsch KD.

Eur J Clin Invest. 1999 Apr;29(4):330-6.

PMID:
10231345
18.

Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.

Macher-Goeppinger S, Aulmann S, Tagscherer KE, Wagener N, Haferkamp A, Penzel R, Brauckhoff A, Hohenfellner M, Sykora J, Walczak H, Teh BT, Autschbach F, Herpel E, Schirmacher P, Roth W.

Clin Cancer Res. 2009 Jan 15;15(2):650-9. doi: 10.1158/1078-0432.CCR-08-0284.

19.
20.

Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.

Salehi E, Vodjgani M, Massoud A, Keyhani A, Rajab A, Shafaghi B, Gheflati Z, Aboufazeli T.

Iran J Immunol. 2007 Dec;4(4):197-205.

PMID:
18057577
Items per page

Supplemental Content

Support Center